Human CD138 ELISA Kit

Contact us
Diaclone
Product Code: 950.640.192
Product Group: ELISA Kits
Supplier: Diaclone
CodeSizePrice
950.640.1922 x 96 (pre-coated)£570.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)

Further Information

Antigen Synonyms:
Syndecan-1
Assay Range:
8-256 ng/ml
Cross reaction:
No cross reactivity with other human soluble molecules
Description:
Diaclone ELISA Kits include pre-coated strip plates biotinylated secondary antibody standards controls (where applicable) buffers streptavidin-HRP TMB stop reagents and a detailed procedure.
Detection Target:
CD138 / Syndecan-1
Incubation:
1h45
Reactivity:
Human
Research Area:
Cell Adhesion
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
4.94 ng/ml
Specificity:
Recognizes natural human soluble syndecan-1

References

  1. Aachmann-AndersenN.J. et al.Physiol Rep. 2018 Mar;6(5):e13573. Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin-angiotensin-aldosterone system.. https://www.ncbi.nlm.nih.gov/pubmed/29504258
  2. Adepu S. et al. Am J Physiol Renal Physiol.2015; 309(2): F137-145. Incipient renal transplant dysfunction associates with tubular syndecan-1 expression and shedding. https://www.ncbi.nlm.nih.gov/pubmed/25972509
  3. Aditianingsih D. et al. BMC Anesthesiol. 2020; 20: 37. . Effects of low versus standard pressure pneumoperitoneum on renal syndecan-1 shedding and VEGF receptor-2 expression in living-donor nephrectomy: a randomized controlled study. https://pubmed.ncbi.nlm.nih.gov/32019488/
  4. Andersen? N.F. et al.Br J Haematol.2005;128:210-217. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. https://www.ncbi.nlm.nih.gov/pubmed/15638855
  5. Annecke T. et al. Br. J. Anaesth.2010;104(4): 414-421. Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. https://www.ncbi.nlm.nih.gov/pubmed/20172938
  6. Benad-Mehner P. et al. J Bone Oncol2014; 3(1): 18-24. Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin.. https://www.ncbi.nlm.nih.gov/pubmed/26909290
  7. Berthelsen RE. Et al. Crit Care. 2019 Sep 5;23(1): 301. Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)-a randomised controlled double-blind investigator-initiated trial investigating safety and efficacy.. https://www.ncbi.nlm.nih.gov/pubmed/31488213
  8. B?eO.W. et al.Am J Case Rep.2018 Feb 16;19:176-182.. Raised Serum Levels of Syndecan-1 (CD138) in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease).. https://www.ncbi.nlm.nih.gov/pubmed/29449526
  9. Bogner-Flatz V. et al. Mediators Inflamm. 2019; 2019: 8071619. . On-the-Scene Hyaluronan and Syndecan-1 Serum Concentrations and Outcome after Cardiac Arrest and Resuscitation. https://www.ncbi.nlm.nih.gov/pubmed/31148947
  10. Bruegger D. et al. Am J Physiol Heart Circ Physiol 2005; 289(5):H1993-9. Atrial natriuretic peptide induces shedding of the endothelial glycocalyx in the coronary vascular bed of guinea pig hearts. https://www.ncbi.nlm.nih.gov/pubmed/15964925
  11. Bruegger D. et al. J. Thorac. Cardiovasc. Surg.2009;138(6): 1445-1447.. Shedding of the endothelial glycocalyx during cardiac surgery: On-pump versus off-pump coronary artery bypass graft surgery. https://www.ncbi.nlm.nih.gov/pubmed/19660323
  12. Cekic C. et al. Gastroenterol Res Pract.2015: 850351. Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease.. https://www.ncbi.nlm.nih.gov/pubmed/26294905
  13. Celie J. W. A. M. et al. Am J Physiol Renal Physiol.2008; 294(1): F253-263.. Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. https://www.ncbi.nlm.nih.gov/pubmed/18032547
  14. Chappell D. et al.Crit Care2014; 18(5): 538. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx.. https://www.ncbi.nlm.nih.gov/pubmed/25497357
  15. Chappell D.et al. Cardiovasc Res.2009; 83(2): 388-396.. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. https://www.ncbi.nlm.nih.gov/pubmed/19307232